Beijing Strong Biotechnologies,Inc. Stock
Equities
300406
CNE100001Y26
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.26 CNY | -3.99% |
|
-5.40% | -35.81% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
| Capitalization | 7.16B 1.01B | P/E ratio 2024 * |
11.7x | P/E ratio 2025 * | 9.43x |
|---|---|---|---|---|---|
| Enterprise value | 7.16B 1.01B | EV / Sales 2024 * |
3.5x | EV / Sales 2025 * | 2.94x |
| Free-Float |
38.66% | Yield 2024 * |
2.04% | Yield 2025 * | 2.49% |
More valuation ratios
* Estimated data
More news
| 1 day | -3.99% | ||
| 1 week | -5.40% | ||
| Current month | -5.40% | ||
| 1 month | -11.80% | ||
| 3 months | -29.17% | ||
| 6 months | -40.11% | ||
| Current year | -35.81% |
1 week
12.18
12.96
1 month
12.1814.35
Current year
12.1821.78
1 year
12.1821.78
3 years
12.1825.59
5 years
12.1825.73
10 years
4.5941.94
| Director | Title | Age | Since |
|---|---|---|---|
Hong Jun Liang
CEO | Chief Executive Officer | 50 | 20-08-12 |
Wei Liu
DFI | Director of Finance/CFO | 55 | 06-12-31 |
Nan Bao
BRD | Director/Board Member | 44 | 04-11-30 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zuo Jun Zou
FOU | Founder | 66 | 01-03-28 |
Xi Liu
FOU | Founder | 62 | 01-03-28 |
Ai Ping Luo
BRD | Director/Board Member | 61 | 11-03-15 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -3.99% | -5.40% | -33.98% | -30.50% | 1.01B | ||
| -1.58% | +0.86% | +13.99% | -4.39% | 13.84B | ||
| -0.81% | +0.57% | +12.63% | +44.44% | 7.45B | ||
| -3.19% | -4.22% | +54.14% | +289.68% | 7.08B | ||
| -0.39% | -2.74% | +8.18% | -49.48% | 5.99B | ||
| +0.80% | +2.43% | +84.40% | -50.20% | 3.34B | ||
| -1.72% | -2.06% | -12.47% | -21.49% | 3.26B | ||
| -1.18% | +1.07% | +18.06% | +487.05% | 2.78B | ||
| -6.91% | -7.75% | -57.07% | -88.72% | 2.6B | ||
| -2.49% | -4.80% | +63.65% | -23.60% | 2.45B | ||
| Average | -2.15% | -0.90% | +15.15% | +55.28% | 4.98B | |
| Weighted average by Cap. | -1.75% | -0.42% | +19.78% | +56.74% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.04B 288M | 2.43B 343M |
| Net income | 619M 87.29M | 763M 108M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,094
Calendar
2024-10-24
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-06 | 12.26 ¥ | -3.99% | 4,628,788 |
| 24-09-05 | 12.77 ¥ | +1.59% | 3,194,100 |
| 24-09-04 | 12.57 ¥ | +0.48% | 2,580,000 |
| 24-09-03 | 12.51 ¥ | +1.62% | 3,694,260 |
| 24-09-02 | 12.31 ¥ | -5.02% | 5,249,721 |
End-of-day quote Shenzhen S.E., September 05, 2024
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.26CNY
Average target price
23.15CNY
Spread / Average Target
+88.83%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300406 Stock